AbbVie Inc.
ABBV
$146.28
-$1.12-0.76%
Weiss Ratings | ABBV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Excellent | |||
Risk Index | Fair | |||
Risk Grade | C+ | |||
Reward Grade | A+ | |||
Rating Factors | ABBV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Good | |||
Growth Index | Excellent | |||
Efficiency Index | Excellent | |||
Solvency Index | Good | |||
Total Return Index | Good | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | ABBV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.27 | |||
Price History | ABBV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -1.63% | |||
30-Day Total Return | -10.43% | |||
60-Day Total Return | 0.52% | |||
90-Day Total Return | 5.22% | |||
Year to Date Total Return | -9.06% | |||
1-Year Total Return | 10.10% | |||
2-Year Total Return | 52.51% | |||
3-Year Total Return | 99.86% | |||
5-Year Total Return | 51.20% | |||
52-Week High % Change | -16.84% | |||
52-Week Low % Change | 9.94% | |||
Price | ABBV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $175.91 | |||
52-Week Low Price | $133.05 | |||
52-Week Low Price (Date) | Feb 02, 2022 | |||
52-Week High Price (Date) | Apr 08, 2022 | |||
Valuation | ABBV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | $258.61B | |||
Enterprise Value | 316.76B | |||
Price/Earnings (TTM) | 19.50 | |||
Earnings Per Share (TTM) | 7.50 | |||
Earnings Per Share Growth | 78.66% | |||
Price/Earnings To Growth | 0.25 | |||
Price/Sales (TTM) | 4.49 | |||
Price/Book (Q) | 16.17 | |||
Enterprise Value/Revenue (TTM) | 5.48 | |||
Price | $146.28 | |||
Enterprise Value/EBITDA (TTM) | 10.61 | |||
Enterprise Value/EBIT | 14.68 | |||
Market Cap Category | Mega Cap | |||
Dividends and Shares | ABBV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 1.776B | |||
Dividend Yield | 3.90% | |||
Div. Per Share (Most Recent) | $1.48 | |||
Dividend Per Share (TTM) | $5.71 | |||
Payout Ratio (TTM) | 73.48% | |||
Dividend Per Share (Most Recent) | $1.48 | |||
Company Info | ABBV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 847 932 7900 | |||
Address | 1 North Waukegan Road North Chicago, IL 60064-6400 | |||
Website | www.abbvie.com | |||
Country | United States | |||
Year Founded | 2012 | |||
Profitability | ABBV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 37.31% | |||
Profit Margin | 23.18% | |||
Management Effectiveness | ABBV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 9.29% | |||
Return on Equity | 90.65% | |||
Income Statement | ABBV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | $57.82B | |||
Total Revenue (TTM) | $57.82B | |||
Revenue Per Share | $32.56 | |||
Gross Profit (TTM) | $40.38B | |||
EBITDA (TTM) | $29.86B | |||
EBIT (TTM) | $21.57B | |||
Net Income (TTM) | $13.41B | |||
Net Income Avl. to Common (TTM) | $13.41B | |||
Total Revenue Growth (Q YOY) | 3.28% | |||
Earnings Growth (Q YOY) | 24.28% | |||
EPS Diluted (TTM) | $7.50 | |||
EPS Diluted Growth (Q YOY) | 24.16% | |||
Balance Sheet | ABBV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | $11.88B | |||
Cash Per Share (Q) | $6.69 | |||
Total Current Assets (Q) | $30.36B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | $16.03B | |||
Current Ratio (Q) | 0.928 | |||
Book Value Per Share (Q) | $9.04 | |||
Total Assets (Q) | $141.33B | |||
Total Current Liabilities (Q) | $32.71B | |||
Total Debt (Q) | $70.00B | |||
Total Liabilities (Q) | $125.30B | |||
Total Common Equity (Q) | $15.99B | |||
Cash Flow | ABBV - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -$1.32B | |||
Cash from Financing (TTM) | -$21.51B | |||
Net Change in Cash (TTM) | -$350.00M | |||
Levered Free Cash Flow (TTM) | $20.24B | |||
Cash from Operations (TTM) | $22.59B | |||